To investigate the endocrine-mediated effects of neonatal administration of the weak estrogenic compounds, bisphenol A, nonylphenol and genistein, were subcutaneously injected with these compounds at doses of 0.1, 1, and 10 µg/rat/day for 5 days starting on postnatal day 1. Rats were autopsied at 47-50 days. Positive control groups were given diethylstilbestrol (DES) at the same dose levels as the other chemicals. The ano-genital distance, age of vaginal opening and preputial separation, and estrus cyclicity for all living offspring were examined. No abnormalities by the injection of nonylphenol and genistein were detected in this study. In the BPA groups, ano-genital distance in the females in the 1 and 10 µg BPA groups was shorter than in the control group, and the ventral prostate weight was higher in the 10 µg BPA group than in the control group. On the other hand, in the DES groups, delayed preputial separation occurred later in the 0.1 and 1 µg groups than in the control group, and in the 10 µg groups, preputial separation was not completed.
, the Organisation for Economic Cooperation and Development (OECD) has proposed using a uterotrophic assay as an in vivo screening tests for estrogenic properties of chemicals and the Hershberger assay as an in vivo screening test for androgenic properties [3] [4] [5] [6] . In addition, the tests described in the enhanced OECD test guideline no. 407 (enhanced TG407) have been developed as assays for detection of endocrine and other mechanisms in mature rats. On the other hand, the neonatal exposure assay has been reported as an assay for detecting endocrine-disrupting activity in the early life stages of rats and mice, and the endocrine-disrupting activity of estrogenic compounds, such as clomiphene, diethylstilbestrol, ethynylestradiol, 17β-estradiol, tamoxifen, bisphenol A, and some phytoestrogens have been detected by this assay [7] [8] [9] [10] [11] [12] [13] [14] . Therefore, this assay is considered to be a useful method for detecting endocrinedisrupting activity. We performed the neonatal exposure assays using the weakly estrogenic compounds, bisphenol A, nonylphenol, and genistein.
The test substances were bisphenol A (BPA, CAS No. 012D2222, Kanto Chemical Co., Tokyo, Japan), p-nnonylphenol (NP, CAS No. 104-40-5, 98.7% pure, Wako Pure Chemicals, Tokyo, Japan), and genistein (CAS No. 4 4 6 -7 2 -0 , 9 8 . 4 % p u r e , W a k o P u r e C h e m i c a l s ) . Diethylstilbestrol (DES, CAS No. 56-53-1, 99.8% pure, Wako Pure Chemicals) was used as the positive control for the estrogenic compounds. Olive oil (Fujimi Pharmaceutical Company, Osaka, Japan) was used as the vehicle.
The study was conducted in two parts because of the small size of the animal room. DES and BPA were tested in Study 1 and DES, NP and genistein in Study 2. Study 2 was performed 2 months after the completion of Study 1. Twenty-five pregnant Crj:CD(SD)IGS female rats on 13 days after mating were purchased from Charles River Japan, Inc. (Shiga, Japan) for each study. At gestational day 19, the dams were weighed, weight-ranked, and randomly assigned 2 dams per group, to the experimental and control groups, and the remaining dams were used in other studies. The pups that were subsequently born were used in this study. Each chemical was administered to all pups for 5 days beginning on postnatal day (PND) 1 (day of birth = PND 0), and on PND 7 the litters were adjusted to four males and four females per dam. When the number of pups of either sex was less than four, the litter size was adjusted to a total of eight pups regardless of sex. The pups were housed with the dams in polycarbonate pens until weaning. All pups were weaned on PND 21, and then housed in stainless steel, wiremesh cages for the remainder of the study. Water was provided automatically, and the animals were given access to a commercial diet (MF, Oriental Yeast Co., Tokyo, Japan) ad libitum. The animal room was maintained at a temperature of 23 ± 2°C and a relative humidity of 55 ± 5%. The room was artificially illuminated with fluorescent light on a 12-hour light/dark cycle (06:00-18:00 h). All animals were cared for according to the principles outlined in the guide for animal experimentation prepared by the Japanese Association for Laboratory Animal Science. Rats were subcutaneously injected with 0, 0.1, 1 or 10 µg/rat/day (approximately 0, 10, 100, and 1000 µg/kg/day body weight) of one of the chemicals or vehicle for 5 days starting on PND 1. We selected the maximum dose of DES as 10 µg/rat/day based on the data of Medlock et al. 11 , and the two lower doses of DES, 1 and 0.1 µg/rat/day, were set and tested with the same doses of BPA, NP, and genistein to determine whether these weakly estrogenic chemicals induce estrogen receptor mediated changes. A vehicle control group given olive oil alone was also established. The volume of the olive oil solutions was 0.05 ml for s.c. injection. The physical stability of each chemical was assessed with a Fourier transform infrared spectrophotometer (FTS-135, Nippon Bio-Rad Laboratories K.K., Tokyo, Japan), and the stability, homogeneity, and concentration of each chemical suspension prepared for administration were confirmed by HPLC. The numbers of pups in each group used to make each observation are shown in Table 1 . The number of pups in the 1 µg/rat/day genistein group was smaller than in the other groups because one dam in the group was accidentally sacrificed after gestational day 19. Clinical signs of all animals were recorded daily. Body weight was measured twice a week throughout the study. Ano-genital distance was measured on PND 7. Vaginal opening and preputial separation were examined. The estrous cycle was evaluated from the day after the first vaginal opening day until the day of necrospy, and rats, including the DES group, were sacrificed in the diestrous stage on PND 47-50 in both studies, except for the rats with persistent estrus vaginal smears which were sacrificed on PND 70. The following organs were weighed: pituitary, testes, epididymides, ventral prostate, seminal vesicle plus coagulating gland with fluid, uterus, and ovaries. The pituitary was weighed after organ fixation. All weighed organs except the testes were fixed in 10% neutral buffered formalin and examined histologically. The testes were fixed in Bouin's solution and examined.
Data were analyzed using Bartlett's test for homogeneity of variance. When the variances were homogeneous at a significance level of 5%, a one-way analysis of variance was performed. If this test yielded a significant difference, the differences between the control group and each of the treatment groups were analyzed by Dunnett's test. When the variances were not homogeneous, the Kruskal-Wallis test was used. If it yielded a significant difference, the differences between the control group and each of the treatment groups were analyzed by a nonparametric Dunnett's test.
No abnormal clinical signs were observed in the rats given any of the compounds. The body weight of the rats given the weakly estrogenic compounds remained normal throughout the study, whereas, the body weight of the female rats receiving DES in Study 2 significantly increased in a dose-dependent manner.
Ano-genital distance in the females in the 1 and 10 µg BPA groups was shorter than in the control group, and no dose-related changes were observed in rats given other compounds ( Table 2 ).
The mean day of vaginal opening did not differ significantly between the control group and the groups given any of the compounds. There were no differences between the mean days of preputial separation in the control group and any of the groups given the weakly estrogenic compounds. However, preputial separation occurred later in the 0.1 and 1 µg DES groups than in the control group, and complete preputional separation was not detected in the rats in the 1 and/or 10 µg DES groups.
No abnormal estrous cycling was detected in the BPA, NP and genistein groups, whereas the estrous stage persisted in all DES groups.
No gross changes were detected in the BPA, NP and genistein groups. However, the seminal vesicle, ventral prostate, and glans penis were smaller in male of the 1 and 10 µg DES groups, and excessive cleavage of the urethral slit, occasionally associated with insufficient raphe formation between the urethral orifice and vagina in female rats, named cleft phallus, hypospadias and small ovaries were observed in all of the females of the DES groups.
Relative organ weight changes of male rats are shown in Tables 3 and 4 . In this study, only the relative weight was evaluated for the organ weight change, because the ages at sacrifice of the rats were different, especially the rats with persistent estrus vaginal smears. Seminal vesicle weight was significantly lower in all genistein groups without doserelation. The ventral prostate weight was higher in the 10 µg BPA group. No dose-related changes were detected in male rats given NP. However, the epididymis, seminal vesicle, and ventral prostate weights were significantly lower in the 1 and/or 10 µg DES groups in Study 1, and in Study 2 the testis and epididymis weights were lower in the 1 and/or 10 µg DES groups, and the seminal vesicle and ventral prostate weights were lower in all DES groups. No dose-related organ weight changes were detected in female rats given any of the weakly estrogenic compounds. On the other hand, the ovary weights were significantly lower in all DES groups, and the uterine weights were lower in all DES groups in Study 1 and in the 10 µg DES group in Study 2.
Histologically, no abnormal findings were detected in the male and female rats given BPA, NP or genistein. However, underdevelopment of the seminal vesicle and prostate was observed in the 1 and 10 µg DES groups, and fewer ovarian corpus lutea, ovarian follicular cysts and uterine glands, as well as increased uterine epithelial height and squamous metaplasia of the glandular epithelium in the uterus were detected in all of the females in the DES groups.
The estrogenic compounds DES, ethynylestradiol, clomiphen, tamoxifen, BPA and 17β-estradiol, all of which except BPA appear to be strongly estrogenic compounds based on their receptor binding affinities and the results of uterotrophic assays [15] [16] [17] , were administered to neonatal rats for a short time, and endocrine-mediated effects were detected [7] [8] [9] [11] [12] [13] [14] . There is an interesting study in which BPA was given to pregnant mice at doses of 10 and 100 mg/kg on gestational days 10-18 resulting in no abnormalities in female offspring, but in which abnormalities such as vaginal epithelial stratification and abnormal estrous cycles were detected in mice given BPA at doses of 15 or 150 µg/mouse for 5 days starting on PND 1 13 . Thus, the neonatal assay method, administered to female neonatal rats for a short time, is considered a useful method for detecting estrogenic activity of chemicals.
The uterotrophic properties of BPA, NP and genistein were detected in the rat immature uterotrophic assay 19 , and abnormal estrous cycles have been observed in rats given BPA 600 mg/kg in a 28-day repeated toxicity test complying with OECD enhanced TG 407 20 . Thus, some estrogen receptor mediated changes caused by BPA, NP and genistein at high dose levels were already known. Vaginal epithelial stratification was observed in mice given 150 µg/kg BPA and abnormal estrous cycles in mice given 15 or 150 µg/ mouse BPA for 5 days beginning on PND 1 13 , but no abnormal changes in reproductive function or histological changes in reproductive organs were observed in rats given 300 µg/kg BPA on the same schedule 2 1 . Also, no abnormalities were detected in male rats given 8 mg/kg NP by intraperitoneal injection from PND 1-10 22 . On the other hand, neonatal exposure to phytoestrogens, such as coumestrol and equol, inhibited uterine gland formation but reproductive organ structure in male rats was not altered by neonatal exposure to coumestrol 10, 23 . In the present study, seminal vesicle weight was lower in all genistein groups without dose-relation and ventral prostate weight was higher in the 10 µg BPA group, but no abnormal histological findings were detected in these groups. We could not speculate on the mechanism of the weight changes in the accessory sex organs. In the present study, each group (per sex and dose) had an average number of 8 pups from only two dams, so, a study to determine the reproducibility of the data in a much larger number of dams will be needed to confirm the findings of the present study. On the other hand, the ano-genital distance (AGD) change in the female BPA groups is suggested to be biologically significant by our background data. The biological and toxicological significances of shortened AGD of female rats are unknown, although a shortened AGD of male rats is one of the parameters of physical feminization. On the other hand, in the DES groups, no significant changes were observed in female AGD. At least, the shortened AGD of female rats in BPA groups were not considered to have originated from the estrogenic activities of BPA. Thus, we concluded that the findings observed in the present study, were not toxicologically relevant changes, and that the present data are valuable in the neonatal exposure assay using weak estrogenic compounds.
In conclusion, there were no toxicologically relevant changes in any parameter of the weak estrogenic compound injected groups under the present experimental conditions. The present data provide valuable information for the neonatal exposure assay using weak estrogenic compounds, although the further studies will be needed.
